EMEA-000812-PIP01-09 - paediatric investigation plan

12 grass pollen extract, cultivated rye pollen extract and birch/alder/hazel pollen extract

Key facts

• Active substance:
  12 grass pollen extract, cultivated rye pollen extract and birch/alder/hazel pollen extract
• Therapeutic area:
  Pneumology-allergology
• Decision number:
  P/220/2010
• PIP number:
  EMEA-000812-PIP01-09
• Pharmaceutical form(s):
  Suspension for injection
• Condition(s) / indication(s):
  Treatment of allergic rhinitis / rhino-conjunctivitis
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  29/10/2010
• Compliance check done:
  No

Decision

P/220/2010: European Medicines Agency decision of 29 October 2010 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for 12 grass pollen extract, cultiva...

Adopted Reference Number: EMA/627976/2010